About The Medical Condition AY 22-989
Find the definition of the medical term AY 22-989. AY 22-989 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
AY 22-989
| AY 22-989 Medical Condition |
|---|
What's The Definition Of The Medical Condition AY 22-989?
A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Guanine Nucleotide Exchange Factors ‐ Protein factors that promote the exchange of GTP for GDP bound…
- Rheumatic Chorea ‐ Acquired and hereditary conditions which feature CHOREA as a…
- Transitional Cell Carcinoma ‐ A malignant neoplasm derived from transitional epithelium, occurring…
- Hydroxymethylbilane Synthetase ‐ An enzyme that catalyzes the formation of hydroxymethylbilane…
- Cervical Ripening ‐ A change in the cervix with respect to its readiness to relax.…
- Evaluations ‐ Studies determining the effectiveness or value of processes,…
- Chromaffin Cell ‐ Cells that store epinephrine secretory vesicles. During times…
- Glutathione S-Transferase 3 ‐ A transferase that catalyzes the addition of aliphatic, aromatic,…
- Alveolodental Membranes ‐ Fibrous connective tissue surrounding the root of a tooth that…
- Soft Tissue Sarcomas ‐ A connective tissue neoplasm formed by proliferation of mesodermal…